Circulating KIM-1 is a minimally invasive biomarker correlated with treatment response to nivolumab in patients with metastatic renal cell carcinoma
循环KIM-1是一种微创生物标志物,与转移性肾细胞癌患者对纳武利尤单抗的治疗反应相关。
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyae327
Chen, Krista Y; Blackford, Amanda L; Sedhom, Ramy; Gupta, Arjun; Hussaini, S M Qasim; Steiner, Clara; Fahlenbrach, Claus; Gilfrich, Christian; Günster, Christian; Jeschke, Elke; Popken, Gralf; Roigas, Jan; Gratzke, Christian; Stolzenburg, Jens-Uwe; Leicht, Hanna; Garinet, Simon; Semaan, Karl; Canniff, John; Phillips, Noa; Davidsohn, Matthew; Berchuck, Jacob; Li, Jiao; Sadagopan, Ananthan; Fortunato, Brad; O’toole, Jillian; Gwo-shu, Mary; Horst, Jack; Freeman, Dory; Seo, Ji-Heui; Freedman, Matthew; Choueiri, Toni; Baca, Sylvan; Viswanathan, Srinivas; Beckermann, Kathryn; Haake, Scott; Reddy, Anupama; Shyr, Yu; Kimryn Rathmell, W; Pal, Sumanta; Ornstein, Moshe; Barata, Pedro; Zhang, Tian; Rini, Brian; Chouieri, Toni; Xu, Wenxin; Vemula, Sai V; Niman, Samuel M; Liu, Xiaowen; Takakura, Ayumi; Huang, Zimo; Choueiri, Toni K; Freedman, Matthew L; Catalano, Paul J; Bonventre, Joseph V; Gupta, Saurabh; McDermott, David F; Bhatt, Rupal S